Sino Biopharmaceutical Limited Stock Analysis

Sino Pink Sheet Analysis Notes

About 48.0% of the company outstanding shares are owned by corporate insiders. The book value of Sino Biopharmaceutica was at this time reported as 1.64. The company has Price/Earnings To Growth (PEG) ratio of 0.53. Sino Biopharmaceutical last dividend was issued on the 6th of September 2022. The entity had 3:2 split on the 4th of June 2018. Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the Peoples Republic of China. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong. Sino Biopharmaceutic is traded on OTC Exchange in the United States.The quote for Sino Biopharmaceutical Limited is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Sino Biopharmaceutical Limited contact Eric Tse at 852 2802 9886 or learn more at https://www.sinobiopharm.com.

Sino Biopharmaceutical Investment Alerts

Sino Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 10.91 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sino Biopharmaceutica's market, we take the total number of its shares issued and multiply it by Sino Biopharmaceutica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Sino Profitablity

The company has Profit Margin (PM) of 0.29 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.

Technical Drivers

As of the 29th of March, Sino Biopharmaceutica has the Risk Adjusted Performance of 0.0694, coefficient of variation of 1358.11, and Variance of 5.03. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sino Biopharmaceutical, as well as the relationship between them. Please validate Sino Biopharmaceutical standard deviation, as well as the relationship between the treynor ratio and kurtosis to decide if Sino Biopharmaceutica is priced more or less accurately, providing market reflects its prevalent price of 0.45 per share. As Sino Biopharmaceutical is a penny stock we also advise to double-check its information ratio numbers.

Sino Biopharmaceutical Price Movement Analysis

Sino Biopharmaceutica Predictive Daily Indicators

Sino Biopharmaceutica Forecast Models

Sino Biopharmaceutica's time-series forecasting models are one of many Sino Biopharmaceutica's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sino Biopharmaceutica's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Sino Biopharmaceutica prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sino shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Sino Biopharmaceutica. By using and applying Sino Pink Sheet analysis, traders can create a robust methodology for identifying Sino entry and exit points for their positions.

When running Sino Biopharmaceutica's price analysis, check to measure Sino Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sino Biopharmaceutica is operating at the current time. Most of Sino Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sino Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sino Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sino Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.